Functional Neurological Disorder — Recognition & Management

Key Points

• Functional neurological disorder is diagnosed by positive clinical signs showing internal inconsistency or a pattern incompatible with recognized neurologic disease—not merely because tests are normal.
• Take a standard neurologic history and examination, identify the positive functional sign, and investigate only enough to address plausible structural disease.
• Effective treatment starts with a clear, nonjudgmental explanation that the nervous system's function is disrupted even though the structure may be intact.
• Use Positive bedside signs and other targeted evaluation to answer specific diagnostic or safety questions rather than ordering broad testing without a plan.
• Escalate urgently for new objective neurologic deficit, altered consciousness, fever, trauma, or other finding that may represent a separate acute neurologic disease.
• Other major warning findings include functional seizures plus possible coexisting epileptic seizures that have not been characterized and iatrogenic harm from repeated emergency procedures, escalating antiseizure medication without epilepsy, or unnecessary surgery/testing.
• Medication and procedural choices should be matched to physiology, contraindications, renal/hepatic function, pregnancy status, and interaction risk when relevant.
• Use rehabilitation goals such as walking, school/work participation, reduced attack frequency, and self-management.

Algorithm

1. Confirm that the presentation is consistent with Functional Neurological Disorder — Recognition & Management and identify immediately life-threatening alternatives or complications.
2. Obtain a focused history and examination that define severity, mechanism, relevant comorbidity, prior treatment, and baseline function.
3. Use targeted evaluation such as Positive bedside signs, Video-EEG, and other tests only when they can change management.
4. Classify the patient into a treatment pathway based on stability, disease/procedure subtype, organ function, and the presence or absence of escalation findings.
5. Begin the first-line intervention described for Functional Neurological Disorder — Recognition & Management, using the least complex safe regimen that directly treats the mechanism.
6. Reassess symptoms, vital signs, examination, laboratory or imaging response, and treatment toxicity after the first clinically meaningful interval.
7. Stop routine progression and escalate care for new objective neurologic deficit, altered consciousness, fever, trauma, or other finding that may represent a separate acute neurologic disease, functional seizures plus possible coexisting epileptic seizures that have not been characterized, or iatrogenic harm from repeated emergency procedures, escalating antiseizure medication without epilepsy, or unnecessary surgery/testing.
8. At discharge or transition, document the final diagnosis, remaining uncertainty, medication/procedure plan, follow-up timing, prevention strategy, and explicit return precautions.

Clinical Synopsis & Reasoning

Functional neurological disorder is diagnosed by positive clinical signs showing internal inconsistency or a pattern incompatible with recognized neurologic disease—not merely because tests are normal. Examples include Hoover sign in functional leg weakness, tremor entrainment or marked variability, and characteristic semiology on video-EEG for functional seizures. Symptoms are genuine and can coexist with epilepsy, migraine, MS, or other neurologic disease.

Take a standard neurologic history and examination, identify the positive functional sign, and investigate only enough to address plausible structural disease. Explain the diagnosis by demonstrating the positive sign when appropriate: for example, involuntary hip extension during contralateral flexion shows preserved motor pathways despite impaired voluntary activation. Avoid framing the disorder as 'nothing is wrong' or as a diagnosis of exclusion after endless testing.

The practical diagnostic task is to decide what must be established immediately, what can be clarified after stabilization, and which finding would change the working diagnosis. Useful evaluation elements include Positive bedside signs, Video-EEG, MRI/other testing, Psychiatric/rehab assessment. Each test should answer a defined question rather than be ordered reflexively. Serial examination is especially important when early results can be normal or when treatment itself changes the physiology being measured.

Neurologic disorders often require careful attention to tempo, distribution, and positive examination findings because the same symptom can arise from very different anatomic mechanisms. For Functional Neurological Disorder — Recognition & Management, the clinician should explicitly separate expected findings from escalation findings such as new objective neurologic deficit, altered consciousness, fever, trauma, or other finding that may represent a separate acute neurologic disease, functional seizures plus possible coexisting epileptic seizures that have not been characterized, or iatrogenic harm from repeated emergency procedures, escalating antiseizure medication without epilepsy, or unnecessary surgery/testing.

Treatment Strategy & Disposition

Effective treatment starts with a clear, nonjudgmental explanation that the nervous system's function is disrupted even though the structure may be intact. FND-informed physical therapy retrains automatic movement and attention; occupational and speech therapy address relevant functional domains. Cognitive behavioral and other psychotherapies can help functional seizures, distress, trauma-related symptoms, and maladaptive illness responses, but psychotherapy is not proof that symptoms are imaginary. Treat depression, anxiety, pain, migraine, sleep problems, and coexisting neurologic disease directly.

Use rehabilitation goals such as walking, school/work participation, reduced attack frequency, and self-management. Relapses are common and should trigger return to learned strategies plus reassessment for genuinely new disease when the phenotype changes.

Treatment should be reassessed after the first meaningful intervention rather than allowed to continue automatically. Relevant medications or therapeutic agents in this topic include No medication directly treats the functional mechanism, SSRI/SNRI when indicated, Antiseizure medication. Their usefulness depends on the indication, patient physiology, and contraindications shown in the sections below. If the response is poorer than expected, revisit the diagnosis, treatment delivery, adherence or access, procedure success when relevant, and the possibility of a complication.

Emergency red flags should be separated from chronic disability management: stabilization and exclusion of time-sensitive structural disease come first, followed by mechanism-specific treatment and rehabilitation. Functional outcomes, cognition, mobility, sleep, mood, and caregiver burden are important longitudinal endpoints in addition to examination findings.

Epidemiology / Risk Factors

• Functional Neurological Disorder — Recognition & Management is a neurologic topic where tempo and examination pattern help distinguish common disease from time-sensitive mimics.
• Disability can persist even after the acute mechanism is treated, making rehabilitation, symptom management, and functional follow-up important parts of care.
• Delayed diagnosis is most harmful when a rapidly progressive, structural, vascular, infectious, or respiratory-threatening process is mistaken for a routine chronic syndrome.

Investigations

Positive FND Signs

Pharmacology

Prognosis / Complications

• Outcome in Functional Neurological Disorder — Recognition & Management depends on baseline severity, underlying mechanism, comorbidity, speed of appropriate treatment, and whether major complications develop.
• Patients who respond as expected still need follow-up focused on recurrence prevention, treatment adverse effects, and restoration of function or physiologic stability.
• The appearance of new objective neurologic deficit, altered consciousness, fever, trauma, or other finding that may represent a separate acute neurologic disease or functional seizures plus possible coexisting epileptic seizures that have not been characterized changes prognosis and should prompt a higher-acuity reassessment rather than routine outpatient progression.
• A durable plan is one that the patient can follow outside the clinical setting and that includes clear thresholds for returning to care.

Patient Education / Counseling

• Explain the diagnosis of Functional Neurological Disorder — Recognition & Management in plain language, including what is known, what remains uncertain, and what the immediate treatment is intended to accomplish.
• Review how the patient should take or use the recommended therapy and what common adverse effects or practical barriers to expect.
• Explain that worsening symptoms are not always a normal part of recovery and give specific return precautions for new objective neurologic deficit, altered consciousness, fever, trauma, or other finding that may represent a separate acute neurologic disease.
• Also seek prompt care for functional seizures plus possible coexisting epileptic seizures that have not been characterized or iatrogenic harm from repeated emergency procedures, escalating antiseizure medication without epilepsy, or unnecessary surgery/testing.
• Discuss prevention or risk reduction relevant to the condition, including medication adherence, follow-up testing, rehabilitation, vaccination, sexual/partner management, or lifestyle factors as appropriate.
• Use teach-back at discharge so the patient or caregiver can state the treatment plan, follow-up timing, and reasons to return.

Notes

The main practical error in Functional Neurological Disorder — Recognition & Management is to reduce the topic to a memorized list without linking each action to a clinical purpose. A safer approach identifies the decision point, chooses the test or intervention that changes that decision, and then reassesses whether the patient is moving in the expected direction. Findings such as new objective neurologic deficit, altered consciousness, fever, trauma, or other finding that may represent a separate acute neurologic disease, functional seizures plus possible coexisting epileptic seizures that have not been characterized, and iatrogenic harm from repeated emergency procedures, escalating antiseizure medication without epilepsy, or unnecessary surgery/testing should move the patient out of a routine pathway and into higher-acuity diagnostic or specialty assessment.

Documentation should make the reasoning reproducible. Record the baseline state, the key evidence supporting the diagnosis, major alternatives that were addressed, treatment actually delivered, response, and the follow-up responsibility. This is particularly important when multiple clinicians will share care or when a procedure, high-risk medication, evolving laboratory abnormality, or time-sensitive infection/vascular syndrome is involved. Once the patient is stable, the remaining work is prevention: address modifiable risk, treatment access, adherence, functional recovery, and the specific complication most likely to cause return to care.

References

1. American Academy of Neurology - Clinical Practice Guidelines — Link
2. American Heart Association/American Stroke Association - Guidelines — Link